People: Catalyst Pharmaceuticals Inc (CPRX.O)

CPRX.O on Consolidated Issue listed on NASDAQ Capital Market

5.23USD
28 Jul 2015
Change (% chg)

-- (--)
Prev Close
$5.23
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
987,391
52-wk High
$5.80
52-wk Low
$2.15

Search Stocks

Miller, Steven 

Dr. Steven R. Miller, Ph.D. is Chief Operating Officer, Chief Scientific Officer of Catalyst Pharmaceutical Partners Inc. Previously, commencing in April 2007, Dr. Miller was Vice President of Pharmaceutical Development and Project Management. Dr. Miller has worked in the healthcare industry for over 25 years. Prior to joining us, Dr. Miller spent 15 years with various divisions of Watson Laboratories, a subsidiary of Watson Pharmaceuticals, Inc., most recently as Executive Director of R&D Operations. In this capacity, Dr. Miller managed a team of 75 in the testing of all R&D products for clinical trials, including method valuation, stability testing, operation of the R&D pilot plant, and assembly of the CMC section of drug applications, in addition to other responsibilities. Prior to holding this position, Dr. Miller was Director of Technology Transfer for Watson Laboratories, and Vice President of Research and Product Development for Royce Laboratories, which was subsequently acquired by Watson Laboratories. Prior to joining Royce Laboratories, Dr. Miller was Group Leader and Senior Scientist at Dade Behring. Prior to that, he served as an Analytical Chemist at the U.S. Food & Drug Administration. Dr. Miller received his Bachelor of Science Degree in Chemistry from the University of Maryland and his Ph.D. from the University of Miami.

Basic Compensation

Total Annual Compensation, USD 400,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 463,334
Fiscal Year Total, USD 863,334

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Patrick McEnany

1,470,890

Alicia Grande

714,113

Steven Miller

863,334

David Muth

--

M. Douglas Winship

258,429

David Caponera

--
As Of  30 Dec 2014
Search Stocks